AI Verdict
RVPH has stronger fundamentals based on our AI analysis.
RVPH vs RVMDW Fundamental Comparison
| Metric | RVPH | RVMDW |
|---|---|---|
| Revenue | $122,867.0 | $0.0 |
| Net Income | $-19.9M | $-1.1B |
| Net Margin | -16,167.8% | N/A |
| ROE | -229.7% | -69.3% |
| ROA | -124.8% | -48.0% |
| Current Ratio | 2.08x | 7.14x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | N/A | $-5.95 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RVPH vs RVMDW: Frequently Asked Questions
Is RVPH or RVMDW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RVPH has stronger fundamentals. RVPH is rated STRONG SELL (90% confidence) while RVMDW is rated STRONG SELL (88% confidence). This is not investment advice.
How does RVPH compare to RVMDW fundamentally?
REVIVA PHARMACEUTICALS HOLDINGS, INC. has ROE of -229.7% vs Revolution Medicines, Inc.'s -69.3%. Net margins are -16,167.8% vs N/A respectively.
Which stock pays higher dividends, RVPH or RVMDW?
RVPH has a dividend yield of N/A or no dividend while RVMDW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RVPH or RVMDW for long term?
For long-term investing, consider that RVPH has STRONG SELL rating with 90% confidence, while RVMDW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RVPH vs RVMDW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVPH vs RVMDW, the AI consensus favors RVPH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.